Literature DB >> 2915734

Tubulointerstitial nephritis associated with pyrazinamide.

S Sanwikarja, R H Kauffmann, J te Velde, J Serlie.   

Abstract

Modern antituberculous therapy consists of a combination of several drugs, some of which (e.g. rifampicin and streptomycin) may cause impairment of renal function. Pyrazinamide therapy has been associated with dose-dependent hepatotoxicity, hyperuricaemia, arthralgia and arthritis. The patient described in this report developed renal failure, fever, arthritis and arthralgia during administration of isoniazid, rifampicin, streptomycin and pyrazinamide. The renal biopsy showed tubulo-interstitial nephritis. After withdrawal of pyrazinamide, while continuing all other drugs, both renal function and histological findings improved which points to an association of renal failure with pyrazinamide.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2915734

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  2 in total

1.  Acute interstitial nephritis during rifampicin therapy can be a paradoxical response: a case report.

Authors:  Jan van der Meulen; Gijs M T de Jong; Pieter J Westenend
Journal:  Cases J       Date:  2009-04-03

2.  Safety of Pyrazinamide for the Treatment of Tuberculosis in Older Patients Over 75 Years of Age: A Retrospective Monocentric Cohort Study.

Authors:  Stella Rousset; Margaux Lafaurie; Hélène Guet-Revillet; Caroline Protin; Jean Le Grusse; Hélène Derumeaux; Peggy Gandia; Fatemeh Nourhashemi; Laurent Sailler; Agnès Sommet; Pierre Delobel; Guillaume Martin-Blondel
Journal:  Drugs Aging       Date:  2020-11-04       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.